AI Article Synopsis
- The article discusses the treatment of ventilator-associated pneumonia, post-SARS-CoV-2 infection, in a young pregnant patient using imipenem, a last-resort antibiotic.
- It highlights the addition of relebactam, a new b-lactamase inhibitor, to enhance the effectiveness of imipenem.
- The introduction outlines how the antibiotic works, its range of effectiveness, and the appropriate dosage for treatment.
Article Abstract
The article describes the use of the last-resort carbapenem antibiotic imipenem in combination with relebactam, a novel b-lactamase inhibitor, in the treatment of ventilator-associated pneumonia developing after SARS-CoV-2 infection in a young pregnant patient. The introduction briefly describes the mechanism and spectrum of activity of the antibiotic, including its dosage.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
ventilator-associated pneumonia
8
pneumonia developing
8
[imipenem-cilastatin-relebactam treat
4
treat ventilator-associated
4
developing infection
4
infection sars-cov-2]
4
sars-cov-2] article
4
article describes
4
describes last-resort
4
last-resort carbapenem
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!